Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation
Yang, James Chih-Hsin, Gadgeel, Shirish M., Sequist, Lecia VanDam, Wu, Chien-Liang, Papadimitrakopoulou, Vassiliki A., Su, Wu-Chou, Fiore, Joseph, Saraf, Sanatan, Raftopoulos, Harry, Patnaik, Amita
Published in Journal of thoracic oncology (01.03.2019)
Published in Journal of thoracic oncology (01.03.2019)
Get full text
Journal Article
Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
Socinski, Mark A, Evans, Tracey, Gettinger, Scott, Hensing, Thomas A, VanDam Sequist, Lecia, Ireland, Belinda, Stinchcombe, Thomas E
Published in Chest (01.05.2013)
Published in Chest (01.05.2013)
Get more information
Journal Article
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer
Chiang, Anne C., Sequist, Lecia Van Dam, Gilbert, Jill, Conkling, Paul, Thompson, Dana, Marcoux, J. Paul, Gettinger, Scott, Kowanetz, Marcin, Molinero, Luciana, O’Hear, Carol, Fassò, Marcella, Lam, Sivuonthanh, Gordon, Michael S.
Published in Clinical lung cancer (01.09.2020)
Published in Clinical lung cancer (01.09.2020)
Get full text
Journal Article